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Abstract
Background: Evidence suggests that in utero exposure to undernutrition and overnutri-
tion might affect adiposity in later life. Epigenetic modification is suggested as a plaus-
ible mediating mechanism.
Methods: We used multivariable linear regression and a negative control design to
examine offspring epigenome-wide DNA methylation in relation to maternal and off-
spring adiposity in 1018 participants.
Results: Compared with neonatal offspring of normal weight mothers, 28 and 1621 CpG
sites were differentially methylated in offspring of obese and underweight mothers,
respectively [false discovert rate (FDR)-corrected P-value<0.05), with no overlap in the sites
that maternal obesity and underweight relate to. A positive association, where higher
methylation is associated with a bodymass index (BMI) outside the normal range, was seen
at 78.6% of the sites associated with obesity and 87.9% of the sites associated with under-
weight. Associations of maternal obesity with offspring methylation were stronger than as-
sociations of paternal obesity, supporting an intrauterine mechanism. There were no con-
sistent associations of gestational weight gain with offspring DNA methylation. In general,
sites that were hypermethylated in association with maternal obesity or hypomethylated in
association with maternal underweight tended to be positively associated with offspring adi-
posity, and sites hypomethylated in association with maternal obesity or hypermethylated
in association with maternal underweight tended to be inversely associated with offspring
adiposity.
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Conclusions: Our data suggest that both maternal obesity and, to a larger degree, under-
weight affect the neonatal epigenome via an intrauterine mechanism, but weight gain
during pregnancy has little effect. We found some evidence that associations of maternal
underweight with lower offspring adiposity and maternal obesity with greater offspring
adiposity may be mediated via increased DNA methylation.
Key words: Epigenetic, ALSPAC, ARIES, causality, epigenome-wide association study, longitudinal, overweight,
overnutrition, undernutrition
Introduction
Evidence from observational studies where pregnant women
have experienced extreme nutritional deficiency suggests
that in utero exposure to such undernutrition might increase
the risk of later-life adiposity in the offspring.1 At the other
extreme, greater maternal body mass index (BMI) at the
start of pregnancy and greater gestational weight gain
(GWG) have also been found to be associated with greater
subsequent offspring adiposity.2–4 Within-sibling studies5,6
and some7,8 though not all9,10 before and after bariatric sur-
gery studies suggest that in cases of extreme maternal adi-
posity these associations might be causal via an intrauterine
mechanism. Together, these results suggest that exposure to
both undernutrition and overnutrition in utero might result
in greater adiposity in later life.
The intrauterine mechanism through which maternal
nutrition might influence long-term offspring adiposity is
unclear. Increasingly, epigenetic modification is suggested
as a plausible mediating causal mechanism,3,11–13 but
evidence for such mediation in human studies is limited.
Epigenetic modifications can cause stable changes to gene
expression and cellular phenotype without altering the
underlying genome. For example, DNA methylation,
which is the most widely-studied epigenetic modification,
involves the addition of methyl groups to DNA at CpG
sites—where cytosine occurs next to guanine in the nucleo-
tide sequence. Four studies, two examining famine experi-
enced during the Dutch Hunger Winter14,15 and two
examining seasonal nutritional variation in the
Gambia,16,17 have reported differential DNA methylation
in offspring exposed to maternal undernutrition during
fetal life compared with those who were not exposed in
utero to maternal undernutrition. At the other extreme of
the BMI distribution, one study found 5698 differentially
methylated CpG sites in the peripheral blood of children
born to morbidly obese mothers prior to bariatric surgery
compared with their siblings born after maternal bariatric
surgery and associated weight loss.18 Others studies have
Key Messages
• This study identified several CpG sites that are differentially methylated in the cord blood of offspring of obese or
underweight mothers compared with offspring of normal weight mothers, with no overlap in the sites that maternal
obesity and underweight relate to. The comparison of underweight with normal weight mothers identified many
more differentially methylated sites (1621) than the comparison of obese with normal weight mothers (28), suggest-
ing that maternal underweight has a larger effect on the fetal epigenome than maternal obesity does. At most sites,
maternal body mass index outside the normal range was associated with higher offspring methylation. The effect of
maternal obesity was stronger than the effect of paternal obesity, supporting an underlying intrauterine mechanism.
• There were no consistent associations of gestational weight gain with DNA methylation in this study.
• In general, sites that were hypermethylated in association with maternal obesity or hypomethylated in association
with maternal underweight tended to be positively associated with offspring adiposity, and sites hypomethylated in
association with maternal obesity or hypermethylated in association with maternal underweight tended to be in-
versely associated with offspring adiposity. This raises the possibility that associations of maternal and offspring adi-
posity, particularly intergenerational persistence of the maternal phenotype, may be mediated by DNA methylation.
• We sought external validation by comparing our associations with those previously reported in the literature. We
identified four studies reporting associations at four loci, but we did not consistently replicate the direction or the
magnitude of these associations.
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found weak or no evidence of associations between mater-
nal BMI and offspring DNA methylation.19–23 Only two
studies have investigated the relationship between DNA
methylation at birth and adiposity in later childhood. Both
studies used a candidate-gene approach and each identified
a single different associated locus.24,25
Thus existing evidence is mixed, and several limitations
make drawing conclusions difficult. Specifically: (i) given
the evidence that both maternal undernutrition and over-
nutrition in pregnancy might influence offspring adiposity,
there may be non-linear associations of the maternal ex-
posures with offspring DNA methylation, which, with one
exception,22 previous studies have not explored; (ii) only
one study24 has looked at the potential mediating role of
methylation between exposure and outcome (i.e. maternal
adiposity in relation to offspring DNA methylation and
offspring DNA methylation in relation to offspring adipos-
ity outcome) in a single study; (iii) only one study20 has
looked at whether associations between maternal adiposity
and offspring DNA methylation persist over time (i.e. as
offspring age), which might be relevant to fully under-
standing mediation mechanisms; and (iv) no study has
applied a causal analysis framework to explore the likeli-
hood of epigenetic mediation being a truly causal process
in this context, independent of confounding or other sour-
ces of bias.
In this paper, our primary aim is to identify differential
methylation in offspring at birth that is associated with
both maternal adiposity in pregnancy and offspring adi-
posity from birth to adolescence. Figure 1 shows the con-
ceptual framework and hypothesized relationships. We
hypothesize that: (i) maternal pre-pregnancy BMI and/or
GWG are associated with differential methylation at CpG
sites in offspring cord blood; (ii) methylation at these sites
is also associated with offspring adiposity (we would also
expect consistency between different measures of adiposity
and age at measurement); and (iii) maternal adiposity is
persistently associated with differential methylation in off-
spring at time points beyond birth. We addressed some
previous limitations in human studies by: (i) testing non-
linear associations of maternal pre-pregnancy BMI or
GWG with DNA methylation; (ii) examining associations
of maternal exposures with offspring methylation at differ-
ent ages and then examining whether identified differen-
tially methylated sites are related to subsequent offspring
adiposity; and (iii) using a negative control (paternal
BMI)26 to explore causation.27
Methods
Participants
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a general population pregnancy cohort study
that initially recruited 14 541 pregnancies with a due date
between April 1991 and December 1992 in Avon, UK.28,29
Written informed consent has been obtained for all
ALSPAC participants. Ethical approval was granted from
the ALSPAC Law and Ethics Committee and the local
Research Ethics Committees. Please note that the study
website contains details of all the data that are available
through a fully searchable data dictionary [http://www.
bris.ac.uk/alspac/researchers/data-access/data-dictionary/].
Blood samples were collected from all consenting ALSPAC
mothers and their offspring at several clinics at different
time points. DNA methylation data for a subset of 1018
Figure 1. A conceptual framework showing the relationships of interest. GWG and maternal BMI are hypothesized to affect offspring adiposity via off-
spring DNA methylation. Specific hypotheses are: (i) maternal pre-pregnancy BMI and/or GWG is associated with differential methylation at CpG sites
in offspring cord blood; (ii) methylation at these sites is also associated with offspring adiposity (we would also expect consistency between different
measures of adiposity and age at measurement); and (iii) maternal adiposity is persistently associated with differential methylation in offspring at
time points beyond birth.
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mother-offspring pairs was generated as part of the
Accessible Resource for Integrated Epigenomics Studies
(ARIES) project [http://www.ariesepigenomics.org.uk/].
ARIES participants were selected based on availability of
DNA samples at two time points for the mother (antenatal
and at follow-up when the offspring were mean age 17.1
years) and three time points for the offspring (neonatal,
childhood, mean age 7.5 and adolescence, mean age 17.1
years). For this study, we used methylation data for 914
mother-neonate, 973 mother-child and 974 mother-adoles-
cent pairs for whom data on all variables of interest were
available.
Measures of maternal and paternal adiposity
Pre-pregnancy BMI
Maternal pre-pregnancy weight and height were self-
reported, and paternal weight and height were reported by
the mother. Data for partners who were not confirmed as
being the biological father of the child by the mothers’ re-
port were excluded. In order to explore the possibility that
systematic bias in partner or self-report weight (e.g. those
who are heavier systematically under-reporting their
weight) might bias our findings, we used Bland-Altman
plots (plots of mean and difference in mean), which
suggested that the level of misreporting is similar for the
majority of participants and is not markedly influenced by
mean weight (more detailed results and plots available as
Supplementary data at IJE online). BMI was calculated
as weight (kg)/height (m2) and categorized according
to World Health Organization categories (underweight
<18.5 kg/m2; normal 18.5–24.9 kg/m2; overweight
25.0–29.9 kg/m2; obese  30.0 kg/m2).
Gestational weight gain
Six trained research midwives abstracted data from obstet-
ric medical records.2,30 These data included every weight
measurement made in antenatal clinics during pregnancy
(median 10 measures per woman, interquartile range: 8 to
11) and the corresponding gestational age and date, as pre-
viously described. Multi-level models were used to derive
the estimated pre-pregnancy weight and GWG per week in
different periods of pregnancy from these repeat measure-
ments as previously described.2,30
We assessed associations with GWG in three ways:
i. Total weight change defined as the last weight minus
the first weight measurement in pregnancy.
ii. According to Institute of Medicine (IoM) recommen-
dations,31 women were categorized as having ad-
equate, less than recommended and excessive GWG.
Using these recommendations, adequate total GWG
as: 12.5–18 kg for underweight women (<18.5 kg/m2);
11.5–16 kg for normal weight women (18.5–24.9 kg/m2);
7–11.5 kg for overweight women (25–29.9 kg/m2); and
5–9 kg for obese women (>30 kg/m2), with women
gaining less that these ranges within each BMI category
defined as having inadequate GWG and those gaining
more as having excessive GWG.
iii. Rate of weight gain per week in early-pregnancy
(between 0 and 18 weeks), mid pregnancy (between 18
and 28 weeks) and late pregnancy (between 28 weeks
and birth) calculated using a multi-level spline model,
as previously reported.2,30 These models were limited
to term (37 weeks of gestation) pregnancies.
Measures of offspring adiposity
Birthweight was extracted from medical records. Height in
childhood [mean age 7.5 years (SD: 0.2)] and adolescence
[mean age 15.5 years (SD: 0.4)] was measured using a
standard protocol to the last complete millimetre using the
Harpenden Stadiometer (Holtain Crosswell, Dyfed, UK).
Weight was measured to the nearest 50 g using the Tanita
Body Fat Analyser (Model TBF 305, Tanita, Arlington
Heights, IL). BMI was calculated as weight (kg)/height
(m2). Waist circumference in childhood and adolescence
(mean ages as above) were measured to the nearest milli-
metre at the minimum circumference of the abdomen be-
tween the iliac crests and the lowest ribs, and the tape was
kept perpendicular to the long axis of the body, touching
the skin but not compressing the tissue. Fat and lean mass
(g) were assessed by whole-body dual-energy X-ray ab-
sorptiometry (DXA) (Prodigy scanner, Lunar Radiation
Corp, Madison, WI, USA) at a mean age of 9.9 years (SD:
0.3) and again at age 15.5 (SD: 0.4).
Methylation data
Full details of the collection and generation of DNA
methylation data are available as Supplementary data at
IJE online.
DNA methylation in cord or peripheral blood was meas-
ured using the Illumina InfiniumVR HumanMethylation
450 K BeadChip assay at the University of Bristol as part of
the ARIES project [ariesepigenomics.org.uk]. The Illumina
InfiniumVR HumanMethylation 450 K BeadChip platform
can detect between-group differences of 20% methylation
with a lower than 1% false-positive rate.32 Data were
pre-processed in R (version 3.0.1) with the WateRmelon
package33 according to the subset quantile normalization
approach described by Touleimat and Tost34 in an
attempt to reduce the non-biological differences between
probes. Allocation to bisulfite conversion batch (96-well
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plate) was identified as the major batch variable likely
to contain systematic bias (Figure S1, available as
Supplementary data at IJE online) so this was controlled for
in all analyses.
Other variables
Maternal age at delivery was derived from the mother’s re-
port of her own and her baby’s dates of birth. Maternal oc-
cupation was classified according to the 1991 British
Office of Population and Census Statistics classification
and categorized for this study as manual or non-manual.
Parity was extracted from medical records and categorized
for this study as nulliparous or parous; maternal smoking
behaviour was assessed during pregnancy via questionnaire
and categorized for this study as: (i) never smoking during
pregnancy; (ii) smoking before pregnancy or in the first tri-
mester and then stopping; or (iii) smoking throughout
pregnancy.
Cell-type proportions were estimated using the
estimateCellCounts function in the minfi R package,35
which is based on the method developed by Houseman.36
This estimated the proportion of B cells, CD8 T cells, CD4
Tcells, granulocytes, NK cells and monocytes in each
sample.
Statistical analysis
We compared mothers in ARIES with those in the rest of
ALSPAC by calculating means and standard deviations for
key characteristics. We used linear regression to confirm
that the associations between maternal adiposity and off-
spring adiposity that have been described in other cohorts,
including ALSPAC,2,37,38 were also present in the ARIES
subset. We used linear regression to investigate associ-
ations between maternal adiposity (exposure) and esti-
mated cell-type proportions in cord blood (outcome).
In order to ensure our analyses were appropriate and
robust, we explored the impact on our results of logit-
transforming methylation b-values to ‘M-values’.39 As
specified in the introduction, we hypothesized that any as-
sociation between maternal adiposity and offspring methy-
lation might be non-linear. We tested this in two ways:
(i) examining associations of maternal BMI categories
(defined using WHO criteria) with epigenome-wide methy-
lation, comparing offspring methylation in offspring from
underweight, overweight and obese mothers with those
from normal weight mothers; and (ii) examining evidence
of departure from linearity with continuously measured
BMI and total and stage-specific GWG by adding a quad-
ratic term to models with these exposures. We also tested
the hypothesis that there may be an interaction between
continuous pre-pregnancy BMI and total GWG or stage-
specific GWG/week in their association with epigenome-
wide offspring methylation. Full details of these analyses
are available as Supplementary data at IJE online (EWAS
Regression Model Optimization).
Epigenome-wide association studies (EWAS) were con-
ducted in R version 3.0.1. We used multiple linear regres-
sion to model maternal pre-pregnancy BMI or GWG as the
exposure and methylation (untransformed b-values) as the
outcome. Bisulfite conversion batch (96-well plate) was
included in all models as a fixed effect (rather than random
effect) to reduce computational intensity. Linear regression
was applied to each CpG site individually and results were
then corrected for multiple testing by controlling the ex-
pected proportion of false-positives among all discoveries
(FDR) using the Benjamini–Hochberg method. The gen-
omic inflation factor (Lambda) and quantile-quantile
(Q-Q) plots were used to compare the genome-wide distri-
bution of P-values with the expected null distribution
(Figure S2, available as Supplementary data at IJE online).
We examined three models: Model 1 adjusted for bisul-
fite conversion batch only; Model 2 adjusted for batch and
covariates: offspring sex, maternal age, parity, smoking
status, occupation, gestational age at birth (only in ana-
lyses where gestational age at birth was not considered to
be on the proposed causal pathway and the exposure meas-
ure was not derived using gestational age at birth—i.e.
total weight gain and IoM-recommended GWG), pre-
pregnancy BMI (where the exposure was not derived using
pre-pregnancy BMI—i.e. total GWG or pregnancy stage-
specific GWG) and weight change in any previous stages of
pregnancy (only in pregnancy stage-specific GWG); and
Model 3 adjusted for batch, covariates as above and esti-
mated cell-type proportions.
EWAS results were summarized as mean (and 95% con-
fidence interval) differences in percentage methylation
(Db*100) per unit exposure for continuous variables and
between groups for binary categorical variables. EWAS
were conducted using methylation data collected at three
time-points – birth, childhood and adolescence.
Cord blood CpG sites associated with maternal adipos-
ity with an FDR-adjusted P-value< 0.05 were taken for-
ward to be assessed in a longitudinal framework.
A multilevel model40,41 including a random intercept and a
linear regression spline term to allow for flexibility was
fitted to each of these sites sequentially. This model is
described in more detail in the supplementary material
available as Supplementary data at IJE online
(Longitudinal Model). Models were adjusted for con-
founders (offspring sex, maternal age, parity, smoking sta-
tus and occupation) and the first 20 independent surrogate
variable components (which account for cellular
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heterogeneity between the cord blood and peripheral blood
cells). To correct for multiple testing, across the CpG sites
and two parameters of (difference in change during child-
hood/adolescence) interest we used a cut-off of 0.05/
(2*number of CpG sites).
Cord blood CpG sites associated with maternal adipos-
ity with an FDR-adjusted P-value< 0.05 were also taken
forward to be assessed in relation to offspring adiposity
using linear regression. We adjusted for bisulfite conver-
sion batch, sex and age at measurement (months). Where
birthweight was the outcome, age was defined as gesta-
tional age at birth. Where waist circumference, fat or lean
mass were the outcomes, we additionally adjusted for
height (cm) at measurement. Results were corrected for
multiple testing using the FDR method and summarized as
mean (and 95% confidence interval) difference in offspring
adiposity per 10% change in methylation level.
Replication and assessing robustness of findings
We assessed the robustness of our findings in two ways.
Firstly, for cord blood CpG sites that were associated with
maternal adiposity (FDR-adjusted P-value< 0.05) we used
a negative control study to explore causality by comparing
these associations with those of paternal adiposity with
cord blood methylation.26 Similar associations for mater-
nal and paternal adiposity with offspring outcomes would
suggest that associations are explained by confounding by
shared familial exposures, whereas a stronger maternal as-
sociation would support a direct intrauterine effect.26
Additionally, we systematically searched the literature for
all published studies that had examined maternal BMI and/
or GWG with cord blood DNA methylation and compared
our findings with findings from those studies.
Results
ARIES sample characteristics
Table S1 (available as Supplementary data at IJE online)
compares the characteristics of mothers in ARIES with
those in the rest of ALSPAC. Mothers included in ARIES
were slightly older, more likely to have a non-manual
occupation and less likely to have smoked throughout
pregnancy.
We confirmed that, in the ARIES subset, maternal pre-
pregnancy BMI was positively associated with measures of
offspring adiposity as previously found for the whole co-
hort with relevant data2 (Table S2, available as
Supplementary data at IJE online). In line with this linear
trend, maternal underweight was inversely associated with
offspring adiposity whereas maternal overweight and, to a
greater extent, obesity were positively associated with off-
spring adiposity. GWG in early and mid pregnancy were
associated with birthweight, but associations with other
measures of childhood adiposity were mostly limited to
late GWG (Table S2, available as Supplementary data at
IJE online).
There were few associations between estimated cell-
type proportions and measures of maternal adiposity
(Table S3, available as Supplementary data at IJE online),
suggesting that our EWAS results are unlikely to be ex-
plained by confounding by cell-type variation. Partly for
this reason, and partly because the estimated cell propor-
tions method uses reference data derived from adult whole
blood that may not be appropriate for cord blood ana-
lysis,36 we favour and therefore report the EWAS results of
Model 2 (adjusted for bisulfite conversion batch and ma-
ternal confounders) over Model 1 (adjusted for bisulfite
conversion batch only) and Model 3 (adjusted for bisulfite
conversion batch, maternal confounders and estimated
cell-type proportions). File S1 (available as Supplementary
data at IJE online) presents the results from all three mod-
els and shows that results are generally similar in the three
models.
After empirical optimization of our regression models
(see Supplementary data available at IJE online: EWAS re-
gression model optimization) in which we confirmed that
the assumption of a linear relationship between BMI/GWG
and cord blood DNA methylation is valid [for 94.2–100%
of probes tested, the model fit was not improved (likeli-
hood ratio test P-value> 0.05) by the inclusion of a quad-
ratic term for pre-pregnancy BMI/GWG], we carried
out EWAS of offspring methylation regressed on pre-
pregnancy BMI or GWG. Figure S2 (available as
Supplementary data at IJE online) shows genomic inflation
values (Lambdas) and quantile-quantile (Q-Q) plots for
each EWAS conducted using Model 2. The numbers
of CpG sites identified by each analysis are provided in
Table S4, and File S1 lists all results with an FDR-adjusted
P-value< 0.05 for each model (available as Supplementary
data at IJE online).
Maternal pre-pregnancy BMI and offspring
methylation at birth
As a continuous variable, maternal pre-pregnancy BMI
(n¼ 727) was positively associated with cord blood methy-
lation at two CpG sites, one at CCDC112 (cg13013671 on
the gene body 200 base pairs from a transcription start
site) and one at MCOLN3 (cg05003422 at a 50 untrans-
lated region), but the effect sizes were small [0.11 (0.07,
0.015) and 0.02 (0.02, 0.03) change in percentage methy-
lation per 1 kg/m2 change in BMI, respectively].
International Journal of Epidemiology, 2015, Vol. 44, No. 4 1293
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Compared with offspring of women who were normal
weight (n¼577), offspring of women who were obese
(n¼ 32) had 28 sites that were differentially methylated and
offspring of women who were underweight (n=24) had a
considerably larger number (1621) of sites that were differ-
entially methylated (FDR-corrected P-value< 0.05; Figure
2). Lambdas did not suggest genomic inflation (Figure S2,
available as Supplementary data at IJE online: 0.998 for ma-
ternal obesity and 0.958 for maternal underweight). There
was no overlap in terms of sites associated with maternal
obesity and sites associated with maternal underweight. A
positive association, where higher methylation is associated
with BMI outside the normal range, was seen at 78.6% of
the sites associated with obesity and 87.9% of the sites
Figure 2. Manhattan plots showing the results of epigenome-wide association studies (EWAS) of cord blood DNA methylation in offspring of under-
weight (n¼ 24), overweight (n¼ 94) and obese (n¼ 32) mothers compared with offspring of normal weight mothers (n¼ 577). The bottom (blue) line
indicates the FDR-adjusted P-value threshold (0.05) and the top (red) line indicates the Bonferroni threshold for genome-wide significance (3.5*107,
i.e. 0.05/284972 probes).
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associated with underweight. Table 1 summarizes the top
five sites with the largest effect sizes and FDR-adjusted P-
values< 0.05. There were no sites that were differentially
methylated in offspring of overweight women (n¼ 94) com-
pared with normal weight women (Figure 2).
The paternal vs maternal effect of obesity
Associations of maternal obesity with offspring cord blood
methylation were of greater magnitude than associations
of paternal obesity with offspring cord blood methylation
at all 28 sites identified through EWAS as associated with
maternal obesity (Figure 3). The maternal associations re-
mained stronger than paternal associations after mutual
adjustment of maternal and paternal BMI. There was only
one underweight father, so we were unable to compare the
effect of maternal and paternal underweight.
Gestational weight gain and offspring methylation
at birth
None of our measurements of GWG [total GWG
(n¼ 673), GWG in early, mid and late pregnancy (n¼ 690)
and IoM-recommended categories of GWG (recommended
GWG n¼ 258, under recommended GWG n¼ 242, over
recommended GWG n¼ 170)] were associated with cord
blood methylation at any site on the array.
Comparison with previously published results
We quantitatively compared our EWAS results to associ-
ations between maternal adiposity and cord blood methyla-
tion that have been previously reported in the literature
(Table S5, available as Supplementary data at IJE
online).21,22,23,24 Our results agreed with the direction of ef-
fect previously reported at one probe at ZCCHC1 and five
probes at PPARGC1A in association with maternal pre-preg-
nancy BMI, one probe at MMP7 in association with GWG in
early pregnancy and 12 probes at RXRA in association with
maternal pre-pregnancy underweight (assumed to be related
to lower maternal carbohydrate intake in early pregnancy,
which was the exposure in the previous study24). However,
with the exception of one probe at RXRA [cg14654324,
1.09(0.43, 1.75) difference in percentage methylation in off-
spring of underweight women compared with normal weight
women, P-value 0.001], confidence intervals crossed the null
and we also found other probes at PPARGC1A, MMP7 and
RXRA that were associated with maternal adiposity in the re-
verse direction to that reported previously.
Persistence of associations at later time-points
Table 2 summarises the results of EWAS (using Model 2)
of maternal adiposity and offspring methylation at the
three time points—birth, childhood and adolescence. Full
results are supplied in File S1 (available as Supplementary
data at IJE online). There was no overlap between time
points in top hits identified, apart from one site
(cg23521281 at WDR75), which was positively associated
with maternal underweight at birth [0.63 (0.33, 0.93)] and
at adolescence [0.77 (0.44, 1.10)]. Of all the exposures,
maternal underweight yielded the highest number of hits at
each time point.
Explicit longitudinal modelling of methylation at sites
identified in cord blood as being associated with maternal
obesity or underweight showed that this lack of overlap in
EWAS hits between time points is likely due to postnatal
Table 1. The top five CpG sites with the largest effect size and FDR-adjusted P-value<0.05 for associations between maternal
pre-pregnancy obesity or underweight and offspring cord blood methylation
Exposure Gene region (CpG) CHR Gene feature
group
Relation to
CpG Island
b (95% CI)* FDR-adjusted
P-value
Pre-pregnancy
maternal
obesity
unnamed (cg00526953) 16 North shore 14.99 (20.89, 9.1) 0.016
SUCLG2 (cg02321096) 3 3’UTR 11.4 (15.78, 7.02) 0.012
FAM129B (cg03270036) 9 Gene body North shore 9.65 (12.92, 6.37) 0.003
KIF15;KIAA1143 (cg17546649) 3 TSS1500; Gene body North shore 7.6 (4.61, 10.59) 0.016
STAB2 (cg23131355) 12 TSS1500 5.05 (6.98, 3.12) 0.011
Pre-pregnancy
maternal
underweight
TEX14 (cg01796478) 17 5’UTR Island 17.57 (8.86, 26.28) 0.021
ZNF783 (cg02373627) 7 Gene body Island 17.19 (24.4, 9.98) 0.003
MVD (cg27467516) 16 Gene body Island 16.55 (24.94, 8.16) 0.027
TMEM201 (cg07232095) 1 Gene body; 3’UTR 13.44 (18.8, 8.08) 0.002
CFHR5 (cg13682187) 1 TSS200 11.88 (6.83, 16.94) 0.004
Models were adjusted for bisulfite conversion batch, offspring sex, maternal age, smoking status, occupation and parity.
CHR, chromosome; TSS-1500, 1500 base-pairs from a transcription start site; TSS-200, 200 base-pairs from a transcription start site; UTR, untranslated
region. Shores are defined according to NCBI guidelines and labelled north (upstream) or south (downstream) of islands.
*b coefficient is mean difference in percentage methylation compared with offspring of normal weight mothers
International Journal of Epidemiology, 2015, Vol. 44, No. 4 1295
 at U
niversity of N
ew
castle on A
pril 5, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
resolution of differential methylation. Full results of this
longitudinal analysis are presented in File S2 (available as
Supplementary data at IJE online). Table 3 and Figure 4a
show results of longitudinal analysis of the top five sites
found differentially methylated in cord blood, between off-
spring of normal weight and obese mothers. At these sites,
changes in methylation were stronger in early/mid child-
hood (age 0 to 7 years) than in late childhood/adolescence
Figure 3. Associations between maternal or paternal obesity and offspring cord blood DNA methylation [mean difference in methylation (%) com-
pared with offspring of normal weight mothers/fathers]. Darker shading indicates a larger effect size (regardless of direction). Models were adjusted
for bisulfite conversion batch, and paternal/maternal continuous BMI where indicated, but no other covariates (n obese mothers¼ 40, n normal
weight mothers¼ 665, n obese fathers¼ 53, n normal weight fathers¼ 372). Stars indicate associations with an FDR-adjusted P-value<0.05.
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(age 7 to 17 years). Differences in methylation change were
found at three of the top five sites. For example, at
cg03270036 (on a CpG island shore at FAM129B), the
estimated cord blood methylation in offspring of obese
mothers was 8.9% lower than in offspring of normal
weight mothers. During early/mid childhood, methylation
decreased in the offspring of normal weight mothers but
increased in the offspring of obese mothers (P-value for
Table 2. The number of CpG sites identified by EWAS as associated with maternal adiposity (FDR-adjusted P-value<0.05) in
cord blood at birth, peripheral blood in childhood and peripheral blood in adolescence. Models were adjusted for bisulfite con-
version batch, offspring sex, maternal age, smoking status, occupation and parity. Models where GWG was the outcome were
additionally adjusted for pre-pregnancy BMI, gestational age at delivery and GWG in the previous stage of pregnancy, where
appropriate
EWAS Neonatal cord blood Child peripheral blood Adolescent peripheral blood
Number of
samples
in analysis
Number of
CpG sites
identified
Number of
samples
in analysis
Number of
CpG sites
identified
Number of
samples in
analysis
Number of
CpG sites
identified
Maternal pre-pregnancy BMI
(continuous)
727 2 770 2 775 0
Maternal obesity 609 (32 obese) 28 646 (26 obese) 2 654 (33 obese) 5
Maternal overweight 671 (94
overweight)
0 710 (98
overweight)
0 716 (95
overweight)
0
Maternal underweight 601 (24
underweight)
1621a 638 (26
underweight)
4 647 (26
underweight)
126
GWG in early pregnancy 690 0 733 0 738 0
GWG in mid pregnancy 690 0 733 0 738 0
GWG in late pregnancy 690 0 733 0 738 0
Total GWG (over entire pregnancy) 673 0 712 0 715 0
Below IOM-recommended GWG 500 (242 under
recommended
GWG)
0 530 (258 under
recommended
GWG)
0 538 (260 under
recommended
GWG)
0
Over IOM-recommended GWG 428 (170 over
recommended
GWG)
0 454 (182 over
recommended
GWG)
0 454 (176 over
recommended
GWG)
0
a1 site is common to birth and adolescence.
Table 3. Longitudinal analysis of top five sites found differentially methylated in cord blood, between offspring of normal weight
and obese mothers
Gene region (CpG) Estimated
cord blood
methylation
in offspring
of normal
weight
mothers (%)
Estimated
cord blood
methylation
in offspring
of obese
mothers (%)
Age 0–7
years:
Average
yearly
change for
offspring of
normal
weight
mothers (%)
Age 0–7
years:
Average
yearly
change for
offspring of
obese
mothers (%)
Age 0–7
years:
P-value for
difference in
methylation
change
Age 7–17
years:
Average
yearly
change for
offspring of
normal
weight
mothers (%)
Age 7–17
years:
Average
yearly
change for
offspring of
obese
mothers (%)
Age 7–17
years:
P-value for
difference in
methylation
change
unnamed (cg00526953) 70.33 66.17 2.00 1.27 0.13 0.49 0.39 0.76
SUCLG2 (cg02321096) 61.60 54.52 0.96 1.84 0.007 0.09 0.13 0.88
FAM129B (cg03270036) 96.92 88.02 0.66 0.77 4.13E-09 0.14 0.32 0.28
KIF15;KIAA1143
(cg17546649)
9.92 14.97 0.46 0.20 0.0003 0.01 0.00 0.90
STAB2 (cg23131355) 92.73 88.21 0.10 0.68 1.29E-05 0.07 0.07 0.96
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Figure 4. Methylation (%) over time for offspring of obese (short dashed (green) line in a) or underweight (short dashed (green) line in b) mothers
compared with offspring of normal weight mothers (long dashed (black) line). Ribbons indicate 95% confidence intervals.
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difference in changes during childhood 4 109), i.e.
methylation differences here were being resolved during
early childhood. During late childhood/adolescence how-
ever, offspring from both BMI groups had decreasing
methylation, with no difference in rate of change. The ef-
fect of cellular heterogeneity from cord to peripheral blood
is strong at cg00526953 (on a CpG island shore at an
uncharacterized locus on chromosome 16): in Figure 4a,
methylation increases during childhood for offspring of
both BMI groups, whereas in Table 3 methylation de-
creases with age. This suggests that changing cell-type pro-
portions are associated with increasing methylation, and
after controlling for this, methylation decreases with age
on average.
Table 4 and Figure 4b show results of longitudinal ana-
lysis of the top five sites found differentially methylated
in cord blood, between offspring of normal weight and
underweight mothers. At these sites, changes in methyla-
tion again acted to resolve differences found in cord blood.
For example, at cg07232095 (on the gene body of
TMEM201), cord blood methylation was almost 12%
higher in the offspring of normal weight mothers. During
childhood however, there was almost no change for these
children, whereas methylation in the offspring of under-
weight mothers increased on average by 1.75% per year.
Methylation at birth and adiposity in childhood
and adolescence
Figure 5 shows effect sizes for associations between methy-
lation at birth and various measures of offspring adiposity
(results are shown for the top 25 CpG sites with the largest
effect sizes and an FDR-adjusted P-value< 0.05 for the as-
sociation between maternal underweight/obesity and cord
blood methylation). In general, sites that were hypermethy-
lated in association with maternal obesity or hypomethy-
lated in association with maternal underweight tended to
be positively associated with offspring adiposity, and sites
hypomethylated in association with maternal obesity or
hypermethylated in association with maternal underweight
tended to be inversely associated with offspring adiposity.
This trend is strongest for birthweight and largely consist-
ent over different measures of offspring adiposity recorded
at different times (Table S6, available as Supplementary
data at IJE online). It should be noted that associations be-
tween offspring adiposity and cord blood methylation at
individual sites did not survive correction for multiple
testing.
Discussion
In support of a previously postulated effect of maternal
adiposity on the offspring epigenome,11,12,13 we found sev-
eral differentially methylated CpG sites in cord blood of
offspring of obese and underweight mothers compared
with offspring of normal weight mothers, with no overlap
in the sites that maternal obesity and underweight relate
to. Despite being less powered to detect associations, the
comparison of underweight with normal weight mothers
identified many more differentially methylated sites (1621)
than the comparison of obese with normal weight women
(28). However, we found no evidence of genomic inflation
in either analysis, suggesting that maternal underweight
has a larger effect on the fetal epigenome than maternal
obesity does, though we acknowledge the need to replicate
our findings. We did not find any differentially methylated
CpG sites when comparing less extreme groups (i.e. off-
spring of overweight mothers compared with offspring of
Table 4. Longitudinal analysis of top five sites found differentially methylated in cord blood, between offspring of normal weight
and underweight mothers
Gene region (CpG) Estimated
cord blood
methylation
in offspring
of normal
weight
mothers (%)
Estimated
cord blood
methylation
in offspring
of under-
weight
mothers (%)
Age 0–7
years:
Average
yearly
change for
offspring of
normal
weight
mothers (%)
Age 0–7
years:
Average
yearly
change for
offspring of
underweight
mothers (%)
Age 0–7
years:
P-value for
difference in
methylation
change
Age 7–17
years:
Average
yearly
change for
offspring of
normal
weight
mothers (%)
Age 7–17
years:
Average
yearly
change for
offspring of
underweight
mothers (%)
Age 7–17
years:
P-value for
difference in
methylation
change
TEX14 (cg01796478) 52.95 63.76 1.03 0.19 0.09 0.28 0.60 0.51
ZNF783 (cg02373627) 89.94 73.92 1.02 1.46 1.94E-05 0.12 0.43 0.44
MVD (cg27467516) 68.14 56.90 0.03 1.75 0.02 0.11 1.05 0.07
TMEM201 (cg07232095) 83.72 71.95 0.00 1.75 3.23E-05 0.11 0.10 0.97
CFHR5 (cg13682187) 25.21 36.63 0.61 0.23 0.01 0.34 0.74 0.09
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Figure 5. Associations between cord blood DNA methylation and offspring adiposity. The heatmaps are built using effect sizes. Positive associations
appear more red and negative associations appear more blue. CpG sites were selected based on their association with maternal underweight or
obesity, the effect size for which is indicated in the far right-hand panel. Stars indicate associations with a P-value< 0.05 (before correction for mul-
tiple testing).
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normal weight mothers) or when assessing methylation in
relation to maternal pre-pregnancy BMI over the whole
distribution (i.e. when BMI was analysed as a continuous
variable). This has implications for future studies of mater-
nal pre-pregnancy BMI and offspring DNA methylation,
which may benefit from taking a similar approach by com-
paring DNA methylation between WHO BMI categories.
Using paternal obesity as a negative control, we found
that for all of the top CpG sites associated with maternal
obesity, the effect on DNA methylation of maternal obesity
was stronger than the effect of paternal obesity, even after
adjustment for paternal BMI. This suggests that the associ-
ations of maternal obesity with offspring methylation at
birth are likely to be causally driven via an intrauterine
mechanism. In line with these findings, we also noted
stronger associations of maternal obesity with offspring
adiposity than equivalent paternal-offspring associations.
Previous studies in ALSPAC that were not restricted only
to those with DNA methylation data have shown that
across the continuum, greater unit maternal BMI is on
average slightly more strongly associated with offspring fat
mass than is paternal BMI, but that study did not look at
BMI categories.38 There were too few underweight fathers
to compare the effects of paternal underweight with mater-
nal underweight on offspring methylation.
We also investigated offspring methylation at birth in
relation to total GWG, GWG in early, mid and late preg-
nancy and IOM categories of recommended GWG, but
found no CpG sites associated with variation in any of
these measures. This might suggest that the associations of
GWG with offspring adiposity that have been reported
previously in ALSPAC2 and other cohorts42–44 are not
mediated by DNA methylation measured in cord blood or
whole blood. However, it should be noted that in the
ARIES subset of ALSPAC, we did not find strong associ-
ations of GWG with offspring adiposity (though these
have been found in the whole cohort2). Additionally, ac-
cording to IoM criteria for recommended GWG, relatively
few (25%) of the women in our study had excessive GWG.
Further exploration in other cohorts with similarly detailed
information on GWG will be necessary before any firm
conclusions can be drawn. Associations between maternal
obesity or maternal underweight and methylation at birth
did not consistently persist to other time points. Compared
with offspring of normal weight mothers, offspring of
mothers who are obese or underweight show differential
methylation at several CpG sites at birth, childhood and
adolescence, but very few sites were common to more than
one time point. Longitudinal analysis revealed that methy-
lation differences between offspring of obese/underweight
mothers and normal weight mothers observed at birth were
being resolved in early childhood. This could suggest that
the association between maternal adiposity and child/ado-
lescent DNA methylation is confounded or mediated by
other factors such as genetic inheritance of adiposity, learnt
eating behaviours, physical activity, stress responses or
other factors arising from a shared environment. Although
associations between maternal adiposity and DNA methyla-
tion at birth do not appear to persist in later life, it is also
possible that variation in the epigenome at birth might have
a phenotypic effect that is not limited to the neonatal
period, but that triggers physiological pathways that have
an apparent impact on the phenotype only in later life.
In contrast to previous observational evidence of a
U-shaped relationship between maternal adiposity/nutri-
tion and offspring adiposity, where extreme obesity/
overnutrition or extreme underweight/undernutrition are
both associated with greater offspring adiposity,1,3,6–8,45
maternal underweight was associated with lower offspring
adiposity and maternal obesity was associated with greater
offspring adiposity in the ARIES cohort. A possible explan-
ation is that, unlike these previous studies, ARIES does not
contain individuals at the far extremes of the BMI distribu-
tions, such as those that might be undergoing bariatric sur-
gery or experiencing famine.
Although we identified associations of maternal under-
weight and obesity with methylation in a number of CpG
sites in offspring cord blood, few robust associations be-
tween methylation at these sites and later offspring adipos-
ity were found. However, there was a general trend
showing that sites that were hypermethylated in associ-
ation with maternal obesity or hypomethylated in associ-
ation with maternal underweight tended to be positively
associated with offspring adiposity, and sites hypomethy-
lated in association with maternal obesity or hypermethy-
lated in association with maternal underweight tended to
be inversely associated with offspring adiposity. This sug-
gests that a linear association (as seen in ALSPAC) between
maternal adiposity and offspring adiposity might be medi-
ated via offspring methylation at birth. However, further
research using larger cohorts and causal analysis tech-
niques such as two-step Mendelian randomization27,46 will
be necessary before confounding can be ruled out. We did
not apply Mendelian randomization in this study because
associations between offspring methylation and adiposity
were weak. As with all areas of research, epigenetic epi-
demiology greatly benefits from attempts to replicate re-
sults in different cohorts. Although we did not conduct a
formal replication analysis in this study, we did quantita-
tively compare our results with those previously reported
in the literature (Table S5, available as Supplementary data
at IJE online).21–24 Our analyses did not consistently repli-
cate the direction or magnitude of all previously reported
associations between maternal adiposity/nutrition and
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CpG site methylation, but we did find the same direction
of association at several sites. These included several
probes on RXRA where we found that maternal under-
weight was associated with greater cord blood methyla-
tion. This is in agreement with Godfrey et al.24 who found
that low maternal carbohydrate intake (in the context of
famine) was associated with greater methylation at this
locus. However, we also found sites at RXRA where ma-
ternal underweight was associated with lower methylation.
Possible reasons for discrepancies between our results in-
clude the fact the mothers included in ALSPAC as a whole
and those selected to ARIES are mostly normal or over-
weight and it is possible that additional associations would
have been seen comparing groups with more extreme BMI
levels. Stringent statistical analysis provides confidence in
our observations, although further work involving meta-
analysis of EWAS results from multiple cohorts and exten-
sive interrogation of potential causal relationships is
warranted.
Limitations of our study include the limited coverage of
the HumanMethylation 450 K array—although the array
provides a relatively inexpensive, high-throughput solution
to epigenome-wide profiling, it only covers around 1.7%
of all CpG sites in the genome.47 Our study relies on data
from cord or peripheral blood leukocytes, which may not
be the most appropriate tissue in which to study associ-
ations with adiposity. Such associations may be tissue-
specific, so future work should focus on more in-depth
analysis of identified loci, possibly using targeted bisulfite
sequencing, in adipose tissue, which is more relevant to the
development of adiposity and may have distinct DNA
methylation signatures.48 Further work to relate changes
in DNA methylation to gene and protein expression will
also be necessary to fully elucidate the mechanisms at play.
It is also possible that pre-pregnancy BMI and GWG alone
are insufficient as markers for over/under-nutrition or sub-
sequent metabolic problems. This might explain the ab-
sence of widespread associations of offspring methylation
with maternal BMI or GWG within women closer to the
healthy range. Measurement error in BMI, in particular the
possibility of systematic error in tself-reported weight,
might have biased our findings. However, our comparisons
of this self-report with predicted pre-pregnancy weight
based on all repeat antenatal clinic measures in mothers
and with measured postnatal weight in fathers suggested
little evidence of systematic mis-reporting. Finally, in our
comparison of associations between maternal vs paternal
obesity and offspring DNA methylation, we did not for-
mally account for the possibility of non-paternity,37,49
although we did exclude partners who were not the biolo-
gical father of the offspring according to the mother’s
report.
In conclusion, we have identified several CpG sites that
are differentially methylated in cord blood of offspring of
obese or underweight mothers compared with offspring of
normal weight mothers and our results suggest an intra-
uterine mechanism. Our results suggest that maternal
underweight might be more influential on offspring DNA
methylation than maternal obesity and weight gain during
pregnancy appears to have little effect. We found some
evidence that associations of maternal adiposity with off-
spring adiposity may be mediated via DNA methylation
in blood. Our findings should be treated with some
caution until they have been replicated in large independ-
ent studies and further exploration of causality with meth-
ods, such as two-step Mendelian randomization, in
collaborations with adequate statistical power have been
completed.
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